TCS 3,299.45 -104.45 (-3.07%) HDFCBANK 1,817.00 +23.30 (1.30%) 
HINDUNILVR 2,244.45 -0.75 (-0.03%) INFY 1,452.30 -44.70 (-2.99%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,743.25 -2.45 (-0.14%) KOTAKBANK 2,132.95 +1.05 (0.05%) ICICIBANK 1,334.95 +5.95 (0.45%) ITC 409.55 +0.25 (0.06%) BAJFINANCE 8,720.85 +122.75 (1.43%) MARUTI 11,481.55 -201.25 (-1.72%) HCLTECH 1,421.80 -49.00 (-3.33%) SBIN 767.80 -11.40 (-1.46%) NESTLEIND 2,261.45 +14.30 (0.64%) ASIANPAINT 2,355.05 +6.35 (0.27%) WIPRO 246.25 -10.15 (-3.96%) DMART 4,039.30 -117.10 (-2.82%) AXISBANK 1,089.50 -0.25 (-0.02%) LT 3,259.20 -159.50 (-4.67%) HDFCLIFE 689.10 -3.80 (-0.55%) SUNPHARMA 1,709.40 -60.70 (-3.43%) ULTRACEMCO 11,496.95 -110.85 (-0.95%) ONGC 226.00 -17.35 (-7.13%) BAJAJFINSV 1,912.15 -8.70 (-0.45%) BPCL 279.40 -7.30 (-2.55%) POWERGRID 293.80 -5.35 (-1.79%) TITAN 3,076.15 -50.10 (-1.60%) BRITANNIA 5,024.85 -50.75 (-1.00%) NTPC 350.45 -8.40 (-2.34%) Download Unicorn Signals App
By EquityPandit
Lupin has received final approval for Calcipotriene Topical Solution, 0.005% (Scalp Solution), from USFDA.
The company has received approval to market a generic version of Dovonex Scalp Solution, 0.005% of Leo Pharmaceutical Products, from the United States Food and Drug Administration (USFDA).
Lupin’s Calcipotriene Topical Solution is suggested for the treatment of chronic, moderately severe psoriasis of the scalp.
Read EquityPandit’s Technical Analysis of Lupin Outlook for the Week
